Filter
529
Filtered Results: 529
Text search:
molecular
markers
Featured
Recommendations
68
New Publications
104
Language
Document type
No document type
242
Guidelines
112
Studies & Reports
98
Manuals
36
Strategic & Response Plan
18
Fact sheets
10
Training Material
7
Situation Updates
5
Resource Platforms
1
Countries / Regions
India
43
Global
23
Africa
14
Latin America and the Carribbean
13
Kenya
12
Tanzania
12
Western and Central Europe
12
Ethiopia
8
Eastern Europe
8
South Africa
7
South–East Asia Region
6
Philippines
5
East and Southern Africa
5
West and Central Africa
5
Sierra Leone
4
Nigeria
4
Uganda
4
Zimbabwe
4
Indonesia
4
Western Pacific Region
4
Asia
4
Cameroon
3
Nepal
3
Pakistan
3
Malawi
3
Brazil
3
Myanmar / Burma
3
Guinea
2
Liberia
2
Congo, Democratic Republic of
2
USA
2
Zambia
2
Syria
2
Benin
2
Ukraine
2
Middle East and North Africa
2
Venezuela
2
North America
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ghana
1
Somalia
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Chad
1
Cambodia
1
Thailand
1
China
1
Rwanda
1
Malaysia
1
Bangladesh
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Angola
1
Lesotho
1
Eastern Europe and Central Asia
1
Timor Leste/ East Timor
1
Georgia
1
Vietnam
1
Japan
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
136
Clinical Guidelines
97
Public Health
38
Pharmacy & Technologies
24
Key Resources
14
Women & Child Health
12
Capacity Building
4
Toolboxes
TB
75
COVID-19
56
AMR
48
HIV
36
NTDs
31
Rapid Response
29
Mental Health
28
Planetary Health
17
NCDs
14
Ebola
10
Refugee
8
Pharmacy
8
Polio
5
Zika
5
Specific Hazards
4
Cholera
3
Conflict
3
Global Health Education
3
Caregiver
3
Disability
2
Natural Hazards
2
Health Financing Toolbox
1
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to political instability over the last 40 years, Peru has experienced major changes on its epidemiological and...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
At its 48th session of Codex Committee on Food Hygiene (CCFH), the Committee noted the importance of water quality and safety in food production and processing. CCFH requested the Food and Agriculture Organization of the United Nations
(FAO) and the World Health Organization (WHO) to provide guidan...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Diabetes mellitus is a major cause of morbidity and mortality in Scotland and worldwide, with an increasing prevalence. In 2009 there were around 228,000 people registered as having diabetes in Scotland, an increase of 3.6% from the preceding year. This increase relates, in part, to the increasing a...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
